Skip to main content

These 6 stocks trade above their 200-DMAs, but are much below their 52-week highs

The 200-day daily moving average (DMA) is used as a key indicator by traders for determining the overall trend in a particular stock. As long as stock is priced above the 200-day SMA on the daily time frame, it is generally considered to be in an overall uptrend. On analysis, We found there are 6 stocks in the Nifty 100 index that are trading above 200-DMA but are still at least 25 percent away from their 52-week highs (Data Source: ACE Equity).

Tata Motors | As on September 28, the stock was trading at Rs 133, which is 34 percent below it 52-week high of Rs 201.70. The 200-DMA value for the stock is Rs 124.

Interglobe Aviation  | As on September 28, the stock was trading at Rs 1275, which is 33 percent below it 52-week high of Rs 1898.85. The 200-DMA value for the stock is Rs 1148.

Bajaj Finance  | As on September 28, the stock was trading at Rs 3335, which is 32 percent below it 52-week high of Rs 4923.40. The 200-DMA value for the stock is Rs 3321

Piramal Enterprises  | As on September 28, the stock was trading at Rs 1283, which is 30 percent below it 52-week high of Rs 1829.49. The 200-DMA value for the stock is Rs 1281.

Siemens  | As on September 28, the stock was trading at Rs 1246, which is 27 percent below it 52-week high of Rs 1717.45. The 200-DMA value for the stock is Rs 1243.


Comments

Post a Comment

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...
Post a Comment
Read more

Brokerages place bets on Titan, see double-digit upside in the stock

Titan can get benefits from the strong market share in the jewellery and wrist watches segment, mainly driven by a wide range of product portfolio catering mainly to the premium and value-added designer jewellery segment. After three consecutive sessions of losses, shares of Titan Company rose over a percent in morning trade on BSE on September 23. The company was dealt a severe blow by COVID-19 as the pandemic triggered strict lockdowns completely battered the retail sector. In the calendar year so far, shares of this one of the largest, most efficient and profitable specialty retailer in India are 7 percent down. The company reported a net standalone loss of Rs 270 crore for the quarter ended June 2020 as the COVID-19 pandemic hit business. The loss was higher than a CNBC-TV18 poll estimate of Rs 175 crore. Standalone revenue during the quarter declined 62.3 percent year-on-year to Rs 1,862 crore compared to the corresponding period last fiscal. Light at the end ...
Post a Comment
Read more

Indigo Paints trades at over 55% premium in grey market after IPO price announcement

The grey market premium has increased significantly from Rs 400-500 on January 11 to Rs 840-850 on January 15. Indigo Paints, one of the fastest-growing paint companies in India, was trading at more than 50 percent premium over its higher issue price band of Rs 1,490 per share in the grey market after the announcement of IPO details. The premium in the grey market as of January 15 was at around Rs 840-850 per share, which means the grey market trading price stood at Rs 2,340-2,330 against the issue price of Rs 1,490, as per the data available on IPO Watch. The premium increased significantly from Rs 400-500 on January 11 to Rs 840-850 today. The grey market is an unofficial trading platform where shares get traded well before the allotment in an initial public offering and till the shares get listed on bourses. It generally estimates the expected listing price of a stock. "Currently Asian paints and Berger paints are trading at a PE of 111 and 148, respectively, while Indigo Paint...
Post a Comment
Read more